Literature DB >> 28861484

Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.

István Ujváry1, Lumír Hanuš2.   

Abstract

Cannabidiol (CBD), the main nonpsychoactive constituent of Cannabis sativa, has shown a wide range of therapeutically promising pharmacological effects either as a sole drug or in combination with other drugs in adjunctive therapy. However, the targets involved in the therapeutic effects of CBD appear to be elusive. Furthermore, scarce information is available on the biological activity of its human metabolites which, when formed in pharmacologically relevant concentration, might contribute to or even account for the observed therapeutic effects. The present overview summarizes our current knowledge on the pharmacokinetics and metabolic fate of CBD in humans, reviews studies on the biological activity of CBD metabolites either in vitro or in vivo, and discusses relevant drug-drug interactions. To facilitate further research in the area, the reported syntheses of CBD metabolites are also catalogued.

Entities:  

Keywords:  biological activity; cannabidiol; metabolites; pharmacokinetics; synthesis

Year:  2016        PMID: 28861484      PMCID: PMC5576600          DOI: 10.1089/can.2015.0012

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  97 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

2.  Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells.

Authors:  Satoshi Yamaori; Yuka Kinugasa; Rongrong Jiang; Shuso Takeda; Ikuo Yamamoto; Kazuhito Watanabe
Journal:  Life Sci       Date:  2015-07-15       Impact factor: 5.037

3.  [Identification of potential cannalis containing substance metabolites: nuclear resonance and mass spectroscopic studies on side chain hydroxylation of cannabinoids].

Authors:  M Binder; S Agurell; K Leander; J E Lindgren
Journal:  Helv Chim Acta       Date:  1974       Impact factor: 2.164

4.  Cannabis metabolites in urine after oral administration.

Authors:  J Christiansen; O J Rafaelsen
Journal:  Psychopharmacologia       Date:  1969

5.  Synthesis of cannabidiols via alkenylation of cyclohexenyl monoacetate.

Authors:  Yuichi Kobayashi; Akira Takeuchi; Yong-Gang Wang
Journal:  Org Lett       Date:  2006-06-22       Impact factor: 6.005

6.  Characterization of blood disappearance and tissue distribution of [3H]cannabidiol.

Authors:  A J Siemens; D Walczak; F E Buckley
Journal:  Biochem Pharmacol       Date:  1980-02       Impact factor: 5.858

7.  Cannabidiol hydroxyquinone-induced apoptosis of splenocytes is mediated predominantly by thiol depletion.

Authors:  Hsin-Ying Wu; Tong-Rong Jan
Journal:  Toxicol Lett       Date:  2010-02-23       Impact factor: 4.372

Review 8.  Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.

Authors:  Sumner Burstein
Journal:  Bioorg Med Chem       Date:  2015-02-07       Impact factor: 3.641

9.  Anticonvulsant activity of four oxygenated cannabidiol derivatives.

Authors:  E A Carlini; R Mechoulam; N Lander
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-09

10.  Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Authors:  Paolo Fusar-Poli; José A Crippa; Sagnik Bhattacharyya; Stefan J Borgwardt; Paul Allen; Rocio Martin-Santos; Marc Seal; Simon A Surguladze; Colin O'Carrol; Zerrin Atakan; Antonio W Zuardi; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2009-01
View more
  52 in total

Review 1.  The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

Authors:  Britta Hahn
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

2.  Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".

Authors:  Marianne Hädener; Tim J Gelmi; Marie Martin-Fabritius; Wolfgang Weinmann; Matthias Pfäffli
Journal:  Int J Legal Med       Date:  2019-01-05       Impact factor: 2.686

Review 3.  Molecular Targets of the Phytocannabinoids: A Complex Picture.

Authors:  Paula Morales; Dow P Hurst; Patricia H Reggio
Journal:  Prog Chem Org Nat Prod       Date:  2017

4.  Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

Authors:  Marta Vázquez; Carlos García-Carnelli; Cecilia Maldonado; Pietro Fagiolino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts.

Authors:  Thivanka Muthumalage; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-19       Impact factor: 4.219

Review 6.  The Essential Medicinal Chemistry of Cannabidiol (CBD).

Authors:  Kathryn M Nelson; Jonathan Bisson; Gurpreet Singh; James G Graham; Shao-Nong Chen; J Brent Friesen; Jayme L Dahlin; Matthias Niemitz; Michael A Walters; Guido F Pauli
Journal:  J Med Chem       Date:  2020-09-10       Impact factor: 7.446

Review 7.  The pharmacokinetics and the pharmacodynamics of cannabinoids.

Authors:  Catherine J Lucas; Peter Galettis; Jennifer Schneider
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

Review 8.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

9.  Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2018-09-17       Impact factor: 4.530

10.  Mechanisms of Action and Pharmacokinetics of Cannabis.

Authors:  Sirichai Chayasirisobhon
Journal:  Perm J       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.